What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Cancer
His main research concerns Internal medicine, Inflammatory bowel disease, Crohn's disease, Ulcerative colitis and Surgery.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Endocrinology.
His Inflammatory bowel disease research includes themes of Epidemiology, Incidence, Intensive care medicine, Pediatrics and Cohort.
Crohn's disease is a subfield of Disease that Peter L. Lakatos studies.
His work investigates the relationship between Ulcerative colitis and topics such as Cohort study that intersect with problems in Natural history.
His studies in Surgery integrate themes in fields like Placebo, Infliximab and Osteoporosis.
His most cited work include:
- Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis (2156 citations)
- Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target. (861 citations)
- The burden of inflammatory bowel disease in Europe. (536 citations)
What are the main themes of his work throughout his whole career to date?
Peter L. Lakatos focuses on Internal medicine, Inflammatory bowel disease, Crohn's disease, Ulcerative colitis and Gastroenterology.
Peter L. Lakatos interconnects Endocrinology and Surgery in the investigation of issues within Internal medicine.
His studies in Inflammatory bowel disease integrate themes in fields like Incidence and Intensive care medicine.
While the research belongs to areas of Crohn's disease, he spends his time largely on the problem of Immunology, intersecting his research to questions surrounding Genotype.
The concepts of his Ulcerative colitis study are interwoven with issues in Colitis, Prospective cohort study and Epidemiology.
His work carried out in the field of Gastroenterology brings together such families of science as Colorectal cancer and Primary sclerosing cholangitis.
He most often published in these fields:
- Internal medicine (65.65%)
- Inflammatory bowel disease (35.28%)
- Crohn's disease (32.36%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (65.65%)
- Inflammatory bowel disease (35.28%)
- Ulcerative colitis (33.16%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Inflammatory bowel disease, Ulcerative colitis, Crohn's disease and Disease.
His Internal medicine study frequently involves adjacent topics like Gastroenterology.
His Inflammatory bowel disease research is multidisciplinary, incorporating perspectives in Clostridium difficile, Therapeutic drug monitoring, Epidemiology, Intensive care medicine and Meta-analysis.
His Ulcerative colitis research incorporates themes from Interquartile range, Dysplasia, Colonoscopy, Prospective cohort study and Endoscopy.
His Crohn's disease study combines topics in areas such as Biomarker, Quality of life, Calprotectin and Referral.
His Disease study combines topics from a wide range of disciplines, such as Hepatology and Population study.
Between 2017 and 2021, his most popular works were:
- Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting. (94 citations)
- Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study. (72 citations)
- Sex-Based Differences in Incidence of Inflammatory Bowel Diseases—Pooled Analysis of Population-Based Studies From Western Countries (57 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
His scientific interests lie mostly in Internal medicine, Inflammatory bowel disease, Ulcerative colitis, Disease and Crohn's disease.
Internal medicine is often connected to Gastroenterology in his work.
His work in Inflammatory bowel disease covers topics such as Epidemiology which are related to areas like Lower risk.
His Ulcerative colitis research integrates issues from Biological drugs, Receiver operating characteristic, Colitis and Hazard ratio.
His biological study spans a wide range of topics, including Combination therapy, Population study, Family medicine and Intensive care medicine.
His Crohn's disease research includes themes of Quality of life, Surgery, Disease severity and C-reactive protein.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
